1056554-91-6Relevant academic research and scientific papers
Novel thioamide derivatives as neutral CB1 receptor antagonists
Bostroem, Jonas,Olsson, Roine I.,Tholander, Joakim,Greasley, Peter J.,Ryberg, Erik,Nordberg, Henrik,Hjorth, Stephan,Cheng, Leifeng
, p. 479 - 482 (2010)
A novel class of cannabinoid-1 (CB1) receptor antagonists for the treatment of obesity is presented. The carboxamide linker in a set of 5,6-diaryl-pyrazine-2-amide derivatives was transformed into the corresponding thioamide, by using a one-pot synthesis. The structural series of thioamides not only showed retained CB1 potency (below 10 nM), but also showed improved solubility. In addition, the neutral antagonist 2c significantly reduced body weight in cafeteria diet obese mice.
